A pilot study evaluating protein abundance in pressure ulcer fluid from people with and without spinal cord injury

Journal of Spinal Cord Medicine

Volumn 38, Issue 4, 2015, Pages 456-467

  Edsberg, Laura E ^a   Wyffels, Jennifer T ^a   Ogrin, Rajna ^b,c   Craven, B Catharine ^d   Houghton, Pamela ^b  

^a DAEMEN COLLEGE   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c Royal District Nursing Service   (Australia)

^d UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Pressure ulcer; Spinal cord injuries; Wound healing

Indexed keywords

ACUTE PHASE PROTEIN; ALBUMIN; C REACTIVE PROTEIN; CALGRANULIN A; CALGRANULIN B; CXCL9 CHEMOKINE; CYTOKINE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; GELATINASE A; GELATINASE B; GROWTH FACTOR; HEMOGLOBIN A1C; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; NERVE GROWTH FACTOR; PROTEIN; PROTEIN S100A12; PROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; PROTEIN S 100; SIGNAL PEPTIDE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADULT; ARTICLE; BIOCHEMICAL ANALYSIS; BLOOD CELL COUNT; BLOOD CHEMISTRY; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DECUBITUS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; IRON BINDING CAPACITY; MALE; MEDIATOR RELEASE; MIDDLE AGED; NURSING HOME; PILOT STUDY; REHABILITATION CENTER; SPINAL CORD INJURY; WOUND FLUID; AGED; CASE CONTROL STUDY; COMPLICATION; METABOLISM; PATHOLOGY; PRESSURE ULCER; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; PILOT PROJECTS; PRESSURE ULCER; S100 PROTEINS; SPINAL CORD INJURIES; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 84941049889     PISSN: 10790268     EISSN: 20457723     Source Type: Journal    
DOI: 10.1179/2045772314Y.0000000212     Document Type: Article

References (70)

1. National Spinal Cord Injury Statistical Center, University of Alabama at Birmingham, 2009 Annual Statistical Report for the Spinal Cord Injury Model Systems-Complete Public Version [document on the internet]. 2010. [archived; cited 2012 Nov 15]. Available from: https://www.nscisc.uab.edu/annualstatreportsarc hives.aspx.
2. Caliri MHL. Spinal cord injury and pressure ulcers. Nurs Clin North Am 2005;40(2):337-47.
3. McKinley WO, Jackson AB, Cardenas DD, DeVivo MJ. Longterm medical complications after traumatic spinal cord injury: a regional model systems analysis. Arch Phys Med Rehabil 1999;80(11):1402-10.
4. Chen Y, Devivo MJ, Jackson AB. Pressure ulcer prevalence in people with spinal cord injury: age-period-duration effects. Arch Phys Med Rehabil 2005;86(6):1208-13.
5. Garber SL, Rintala DH, Hart KA, Fuhrer MJ. Pressure ulcer risk in spinal cord injury: predictors of ulcer status over 3 years. Arch Phys Med Rehabil 2000;81(4):465-71.
6. National Pressure Ulcer Advisory Panel and European Pressure Ulcer Advisory Panel. In: Prevention and treatment of pressure ulcers: clinical practice guideline. Washington, DC: National Pressure Ulcer Advisory Panel; 2009. pp. 21-50.
7. Rodriguez GP, Clauss-Walker J, Kent MC, Garza HM. Collagen metabolite excretion as a predictor of bone and skin related complications in spinal cord injury. Arch Phys Med Rehabil 1989;70(6): 442-4.
8. Rodriguez GP, Clauss-Walker J. Biochemical changes in skin composition in spinal cord injury. Paraplegia 1988;26(5):302-9.
9. Rodriguez GP, Claus-Walker J, Kent MC, Stal S. Adrenergic receptors in insensitive skin of spinal cord injured patients. Arch Phys Med Rehabil 1986;67(3):177-80.
10. Rodriguez GP, Garber SL. Prospective study of pressure ulcer risk in spinal cord injury patients. Paraplegia 1994;32(3):150-8.
11. Mast BA, Schultz GS. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regen 1996;4(4):411-20.
12. Staiano-Coico L, Higgins PJ, Schwartz SB, Zimm AJ, Goncalves J. Wound fluids: a reflection of the state of healing. Ostomy Wound Manage 2000;46 (1A Suppl):85S-93S; quiz 94S-95S.
13. Bennett NT, Schultz GS. Growth factors and wound healing: biochemical properties of growth factors and their receptors. Am J Surg 1993;165(6):728-37.
14. Mackie EJ, Halfter W, Liverani D. Induction of tenascin in healing wounds. J Cell Biol 1988;107(6 pt 2):2757-67.
15. Moulin V. Growth factors in skin wound healing. Eur J Cell Biol 1995;68(1):1-7.
16. Armstrong DG, Jude EB. The role of matrix metalloproteinases in wound healing. J Am Podiatr Med Assoc 2002;92(1):12-8.
17. Baker EA, Leaper DJ. Proteinases, their inhibitors, and cytokine profiles in acute wound fluid. Wound Repair Regen 2000;8(5):392-8.
18. Tarnuzzer RW, Schultz GS. Biochemical analysis of acute and chronic wound environments. Wound Repair Regen 1996;4(3):321-5.
19. Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci 2004;9:283-9.
20. Segal JL, Gonzales E, Yousefi S, Jamshidipour L, Brunnemann SR. Circulating levels of IL-2R, ICAM-1, and IL-6 in spinal cord injuries. Arch Phys Med Rehabil 1997;78(1):44-7.
21. Schäffer M, Barbul A. Lymphocyte function in wound healing and following injury. Br J Surg 1998;85(4):444-60.
22. Lawrence WT. Physiology of the acute wound. Clin Plast Surg 1998;25(3):321-40.
23. Micera A, Vigneti E, Pickholtz D, Reich R, Pappo O, Bonini S, et al. Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc Natl Acad Sci USA 2001;98(11):6162-7.
24. Parks WC. The production, role, and regulation of metalloproteinases in the healing epidermis. Wounds, Compend Clin Res Pract 1995;7:23A-33A.
25. Yager DR, Nwomeh BC. The proteolytic environment of chronic wounds. Wound Repair Regen 1999;7(6):433-41.
26. Ladwig GP, Robson MC, Liu R, Kuhn MA, Muir DF, Schultz GS. Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers. Wound Repair Regen 2002;10(1): 26-37.
27. Lazarus GS, Cooper DM, Knighton DR, Percoraro RE, Rodeheaver G, Robson MC. Definitions and guidelines for assessment of wounds and evaluation of healing. Wound Repair Regen 1994;2(3):165-70.
28. Vaalamo M, Mattila L, Johansson N, Kariniemi AL, Karjalainen-Lindsberg ML, Kähäri VM, et al. Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J Invest Dermatol 1997;109(1):96-101.
29. Cook H, Davies KJ, Harding KG, Thomas DW. Defective extracellular matrix reorganization by chronic wound fibroblasts is associated with alterations in TIMP-1, TIMP-2, and MMP-2 activity. J Invest Dermatol 2000;115(2):225-33.
30. James TJ, Hughes MA, Cherry GW, Taylor RP. Simple biochemical markers to assess chronic wounds. Wound Repair Regen 2000;8(4):264-9.
31. Moses MA, Marikovsky M, Harper JW, Vogt P, Eriksson E, Klagsbrun M, et al. Temporal study of the activity of matrix metalloproteinases and their endogenous inhibitors during wound healing. J Cell Biochem 1996;60(3):379-86.
32. Wagner S, Coerper S, Fricke J, Hunt TK, Hussain Z, Elmlinger MW, et al. Comparison of inflammatory and systemic sources of growth factors in acute and chronic human wounds. Wound Repair Regen 2003;11(4):253-60.
33. Weckroth M, Vaheri A, Lauharanta J, Sorsa T, Konttinen YT. Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers. J Invest Dermatol 1996;106(5):1119-24.
34. Edsberg LE, Wyffels JT, Brogan MS, Fries KM. Analysis of the proteomic profile of chronic pressure ulcers. Wound Repair Regen 2012;20(3):378-401.
35. Hsu K, Champaiboon C, Guenther BD, Sorenson BS, Khammanivong A, Ross KF, et al. Anti-infective protective properties of S100 calgranulins. Antiinflamm Antiallergy Agents Med Chem 2009;8(4):290-305.
36. Cruse JM, Lewis RE, Dilioglou S, Roe DL, Wallace WF, Chen RS. Review of immune function, healing of pressure ulcers, and nutritional status in patients with spinal cord injury. J Spinal Cord Med 2000;23(2):129-35.
37. Davies AL, Hayes KC, Dekaban GA. Clinical correlates of elevated serum concentrations of cytokines and autoantibodies in patients with spinal cord injury. Arch Phys Med Rehabil 2007;88(11):1384-93.
38. Vaziri ND, Eltorai I, Gonzales E, Winer RL, Pham H, Bui TD, et al. Pressure ulcer, fibronectin, and related proteins in spinal cord injured patients. Arch Phys Med Rehabil 1992;73(9): 803-6.
39. Scivoletto G, Fuoco U, Morganti B, Cosentino E, Molinari M. Pressure sores and blood and serum dysmetabolism in spinal cord injury patients. Spinal Cord 2004;42(8):473-6.
40. Hayes KC, Hull TCL, Delaney GA, Potter PJ, Sequeira KA, Campbell K, et al. Elevated serum titers of proinflammatory cytokines and CNS autoantibodies in patients with chronic spinal cord injury. J Neurotrauma 2002;19(6):753-61.
41. Malaguarnera M, Di Fazio I, Vinci E, Bentivegna P, Mangione G, Romano M. Haematologic pattern in healthy elderly subjects. Panminerva Med 1999;41(3):227-31.
42. Brigden ML. Clinical utility of the erythrocyte sedimentation rate. Am Fam Physician 1999;60(5):1443-50.
43. Hutchinson WL, Koenig W, Fröhlich M, Sund M, Lowe GD, Pepys MB. Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population. Clin Chem 2000;46(7):934-8.
44. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003;111(12):1805-12.
45. Hirsch GH, Menard MR, Anton HA. Anemia after traumatic spinal cord injury. Arch Phys Med Rehabil 1991;72(3): 195-201.
46. Iizaka S, Sanada H, Nakagami G, Sekine R, Koyanagi H, Konya C, et al. Estimation of protein loss from wound fluid in older patients with severe pressure ulcers. Nutrition 2010;26(9): 890-5.
47. Iizaka S, Sanada H, Minematsu T, Oba M, Nakagami G, Koyanagi H, et al. Do nutritional markers in wound fluid reflect pressure ulcer status? Wound Repair Regen 2010;18(1):31-7.
48. Shahin ES, Meijers JM, Schols JM, Tannen A, Halfens RJ, Dassen T. The relationship between malnutrition parameters and pressure ulcers in hospitals and nursing homes. Nutrition 2010;26(9):886-9.
49. Beers MH, Berkow R. The Merck manual of geriatrics. 3rd ed. West Point, PA: Merck & Co., Inc.; 2000.
50. Edwards N, Baird C. Interpreting laboratory values in older adults. Medsurg Nurs 2005;14(4):220-9; quiz 230.
51. Trengove NJ, Langton SR, Stacey MC. Biochemical analysis of wound fluid from nonhealing and healing chronic leg ulcers. Wound Repair Regen 1996;4(2):234-9.
52. Yager DR, Zhang LY, Liang HX, Diegelmann RF, Cohen IK. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Invest Dermatol 1996;107(5):743-8.
53. Xia YP, Zhao Y, Tyrone JW, Chen A, Mustoe TA. Differential activation of migration by hypoxia in keratinocytes isolated from donors of increasing age: implication for chronic wounds in the elderly. J Invest Dermatol 2001;116(1):50-6.
54. Ryckman C, Vandal K, Rouleau P, Talbot M, Tessier PA. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immunol 2003;170(6):3233-42.
55. Sorci G, Riuzzi F, Giambanco I, Donato R. RAGE in tissue homeostasis, repair and regeneration. Biochim Biophys Acta 2013;1833(1):101-9.
56. Caldwell RL, Opalenik SR, Davidson JM, Caprioli RM, Nanney LB. Tissue profiling MALDI mass spectrometry reveals prominent calcium-binding proteins in the proteome of regenerative MRL mouse wounds. Wound Repair Regen 2008;16(3):442-9.
57. Leach ST, Yang Z, Messina I, Song C, Geczy CL, Cunningham AM, et al. Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease. Scand J Gastroenterol 2007;42(11):1321-31.
58. Stríz I, TrebichavskýI. Calprotectin - a pleiotropic molecule in acute and chronic inflammation. Physiol Res 2004;53(3):245-53.
59. Foell D, Seeliger S, Vogl T, Koch H-G, Maschek H, Harms E, et al. Expression of S100A12 (EN-RAGE) in cystic fibrosis. Thorax 2003;58(7):613-7.
60. Eckert RL, Broome A-M, Ruse M, Robinson N, Ryan D, Lee K. S100 proteins in the epidermis. J Invest Dermatol 2004;123(1): 23-33.
61. Thorey IS, Roth J, Regenbogen J, Halle JP, Bittner M, Vogl T, et al. The Ca2+-binding proteins S100A8 and S100A9 are encoded by novel injury-regulated genes. J Biol Chem 2001;276(38):35818-25.
62. Eming SA, Koch M, Krieger A, Brachvogel B, Kreft S, Bruckner-Tuderman L, et al. Differential proteomic analysis distinguishes tissue repair biomarker signatures in wound exudates obtained from normal healing and chronic wounds. J Proteome Res 2010;9(9):4758-66.
63. Krisp C, Jacobsen F, McKay MJ, Molloy MP, Steinstraesser L, Wolters DA. Proteome analysis reveals antiangiogenic environments in chronic wounds of diabetes mellitus type 2 patients. Proteomics 2013;13(17):2670-81.
64. Zhu P, Ren M, Yang C, Hu Y-X, Ran J-M, Yan L. Involvement of RAGE, MAPK and NF-êB pathways in AGEs-induced MMP-9 activation in HaCaT keratinocytes. Exp Dermatol 2012;21(2): 123-9.
65. Campagnolo DI, Keller SE, DeLisa JA, Glick TJ, Sipski ML, Schleifer SJ. Alteration of immune system function in tetraplegics. A pilot study. Am J Phys Med Rehabil 1994;73(6):387-93.
66. Iversen PO, Hjeltnes N, Holm B, Flatebo T, Strom-Gundersen I, Ronning W, et al. Depressed immunity and impaired proliferation of hematopoietic progenitor cells in patients with complete spinal cord injury. Blood 2000;96(6):2081-3.
67. Oviedo-Orta E, Bermudez-Fajardo A, Karanam S, Benbow U, Newby AC. Comparison of MMP-2 and MMP-9 secretion from T helper 0, 1 and 2 lymphocytes alone and in coculture with macrophages. Immunology 2008;124(1):42-50.
68. Wiegand C, Schönfelder U, Abel M, Ruth P, Kaatz M, Hipler U-C. Protease and pro-inflammatory cytokine concentrations are elevated in chronic compared to acute wounds and can be modulated by collagen type I in vitro. Arch Dermatol Res 2010;302(6): 419-28.
69. Clarke MS, Bamman MM, Feeback DL. Bed rest decreases mechanically induced myofiber wounding and consequent wound-mediated FGF release. J Appl Physiol 1998;85(2): 593-600.
70. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003;83(3):835-70.